Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.

Unlike the investment banks, we created StockStory to provide independent analysis that helps you determine which companies are truly worth following. Keeping that in mind, here are three stocks where Wall Street’s estimates seem disconnected from reality and some better opportunities to consider.

BILL (BILL)

Consensus Price Target: $57.86 (52.2% implied return)

Transforming the messy back-office financial operations that plague small business owners, BILL (NYSE: BILL) provides a cloud-based platform that automates accounts payable, accounts receivable, and expense management for small and midsize businesses.

Why Should You Dump BILL?

1. Offerings struggled to generate meaningful interest as its average billings growth of 11.7% over the last year did not impress
2. Customer acquisition costs take a while to recoup, making it difficult to justify sales and marketing investments that could increase revenue
3. Operating margin didn’t move over the last year, showing it couldn’t increase its efficiency

BILL is trading at $38.03 per share, or 2.2x forward price-to-sales. To fully understand why you should be careful with BILL, check out our full research report (it’s free).

Columbus McKinnon (CMCO)

Consensus Price Target: $26.50 (81.1% implied return)

With 19 different brands across the globe, Columbus McKinnon (NASDAQ: CMCO) offers material handling equipment for the construction, manufacturing, and transportation industries.

Why Do We Steer Clear of CMCO?

1. Products and services are facing end-market challenges during this cycle, as seen in its flat sales over the last two years
2. Expenses have increased as a percentage of revenue over the last five years as its operating margin fell by 7.6 percentage points
3. Performance over the past two years shows each sale was less profitable, as its earnings per share fell by 10.5% annually

Columbus McKinnon’s stock price of $14.63 implies a valuation ratio of 9x forward P/E. Read our free research report to see why you should think twice about including CMCO in your portfolio.

Globe Life (GL)

Consensus Price Target: $171.73 (23.7% implied return)

With roots dating back to 1900 and a rebranding from Torchmark Corporation in 2019, Globe Life (NYSE: GL) is an insurance holding company that offers life insurance, supplemental health insurance, and annuity products through various distribution channels.

Why Do We Think Twice About GL?

1. 4.5% annual revenue growth over the last two years was slower than its insurance peers
2. Sluggish 4.8% annualized growth in net premiums earned over the last two years indicates the firm trailed its insurance peers
3. Book value per share tumbled by 2.2% annually over the last five years, showing insurance sector trends are working against its favor during this cycle

At $138.82 per share, Globe Life trades at 1.6x forward P/B. Dive into our free research report to see why there are better opportunities than GL.

High-Quality Stocks for All Market Conditions

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it's flagging for this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.